about
Diffusion-weighted MRI of breast lesions: a prospective clinical investigation of the quantitative imaging biomarker characteristics of reproducibility, repeatability, and diagnostic accuracy.Quantitative apparent diffusion coefficient measurements obtained by 3-Tesla MRI are correlated with biomarkers of bladder cancer proliferative activity18F-FDG PET/CT and PET/MRI Perform Equally Well in Cancer: Evidence from Studies on More Than 2,300 Patients.MR-guided vacuum-assisted breast biopsy of MRI-only lesions: a single center experience.MRI-only lesions: application of diffusion-weighted imaging obviates unnecessary MR-guided breast biopsies.Diagnostic utility of second-look US for breast lesions identified at MR imaging: systematic review and meta-analysis.Benign (BI-RADS 2) lesions in breast MRI.Synthesis and preclinical evaluation of an Al18F radiofluorinated GLU-UREA-LYS(AHX)-HBED-CC PSMA ligand.Human Biodistribution and Radiation Dosimetry of 18F-Clofarabine, a PET Probe Targeting the Deoxyribonucleoside Salvage Pathway.Evaluation of Prostate Cancer with 11C-Acetate PET/CT.Malignancy rates and diagnostic performance of the Bosniak classification for the diagnosis of cystic renal lesions in computed tomography - a systematic review and meta-analysis.68Ga-DOTATATE PET/CT Interobserver Agreement for Neuroendocrine Tumor Assessment: Results of a Prospective Study on 50 Patients.Automatic quantification of multi-modal rigid registration accuracy using feature detectors.A simple classification system (the Tree flowchart) for breast MRI can reduce the number of unnecessary biopsies in MRI-only lesions.Rate of malignancy in MRI-detected probably benign (BI-RADS 3) lesions.MR arthrography of the shoulder: do we need local anesthesia?Quantitative apparent diffusion coefficient as a noninvasive imaging biomarker for the differentiation of invasive breast cancer and ductal carcinoma in situ.Diffusion-weighted imaging of breast lesions: Region-of-interest placement and different ADC parameters influence apparent diffusion coefficient values.[Researcher of the month].Detection of Bone Metastases Using 11C-Acetate PET in Patients with Prostate Cancer with Biochemical Recurrence.Clinical application of Acoustic Radiation Force Impulse Imaging with Virtual Touch IQ in breast ultrasound: diagnostic performance and reproducibility of a new techniqueBreast MRI used as a problem-solving tool reliably excludes malignancyMultiparametric MRI of the prostate at 3 T: limited value of 3D (1)H-MR spectroscopy as a fourth parameterResponse
P50
Q31123171-26B888B0-29F3-453E-8D28-8DFDED73BED5Q34155874-597A539E-348C-4190-A9C8-E59BF7D58AF1Q37214513-3795AD4E-D224-4DE0-8ACB-AA186324DE48Q37314182-CCA3CC14-C6ED-421A-87F5-258249F32847Q38202564-2C4A7FA4-B356-45B8-97E0-F50F1AEC1362Q38239540-FF6A04B8-8157-428C-A38A-0C2C08FCEFF7Q38343353-DB3D90A5-B0D9-4C9D-A2AC-126F12E42941Q38762963-5491F872-B73E-47E8-A899-E1280C0FBB4AQ38798869-218BC81E-D996-4781-828C-2C25A053FDB6Q38970098-787DF79B-6AA5-498A-9777-12D702B49755Q38985778-CE784826-F6CE-44EB-BFA3-45B785671276Q39475351-B23352C5-5E74-4951-951E-1766E1F2B5B9Q39649643-C0D305EA-298B-449B-BFD5-66247C9E4AE0Q41261421-257B72F4-2C09-46A9-9009-D2AAE04CDF99Q43983124-EDBFCA74-5BCA-42F1-86D2-1485CCCA5AACQ47889232-36ED050E-D1B6-4033-929B-FB884E5F1799Q51021731-E638F83C-6CF7-49A2-8654-3F5FC4B120D1Q51830723-9C9E42C9-778C-4F7E-9CB2-CE53CE64041BQ52710485-7B28BE82-468E-4F0C-8308-23885251E2CFQ52987259-AF111165-574E-460B-909A-18E90FE3EB04Q60314485-CF8AA8C1-7AE1-4AE0-9767-99E89BCCB610Q86122477-FAE2AD53-FF24-4258-AEFE-5AB739A729A8Q86268475-4184C3D9-8FD7-4531-BE20-BBD20EFF3A2AQ95784537-A0798157-0C9E-4EF2-835C-3024B2047A29
P50
description
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Claudio Spick
@ast
Claudio Spick
@en
Claudio Spick
@es
Claudio Spick
@nl
type
label
Claudio Spick
@ast
Claudio Spick
@en
Claudio Spick
@es
Claudio Spick
@nl
prefLabel
Claudio Spick
@ast
Claudio Spick
@en
Claudio Spick
@es
Claudio Spick
@nl
P106
P21
P31
P496
0000-0002-2628-0907